INSTILLATION OF TAUROLOCK™ 25.000 IU ALWAYS FOLLOW THE MANUFACTURER’S INSTRUCTIONS THAT ACCOMPANY THE PARTICULAR VASCULAR ACCESS PRODUCT UTILISED.
1. Flush the device with 10ml of saline. 2. Dissolve TauroLock-U25000 (Figure A) by adding 5ml of TauroLock (Figure B) to the vial using a noncoring needle.
FIGURE A
FIGURE B
3. Withdraw the clear solution TauroLock-U25000 from the ampoule (Figure B) using an appropriate syringe. The reconstituted TauroLock-U25000 solution must be used immediately.
4. Instil TauroLock-U25000 slowly (for adults no more than 1ml per second, for infants and children under 2 years of age no more than 1ml per 5 seconds) into the access device in a quantity sufficient to fill the lumen completely. IMPORTANT: Consult the manufacturers instruction for the specific fill volume during implantation. This volume has to be strictly respected. TauroLock-U25000 will remain inside the access device until the next treatment.
THE QUALITY OF THE UROKINASE USED IN TAUROLOCK-U25000 IS GRADED ACCORDING TO EUROPEAN PHARMACOPOEIA (PH. EUR.) (= DRUG QUALITY). TAUROLOCK-U25000 IS A MEDICAL DEVICE.
5. Prior to the next treatment TauroLock-U25000 must be aspirated and discarded according to the Trust’s waste guidelines. 6. Flush the device with 10ml of saline.
L-0182-0037-A1 | FEBRUARY 2019